In the long human struggle to understand how a virus transforms a body into its own instrument of harm, researchers at institutions across the United States and United Kingdom have identified a molecular actor — a microRNA called miR-2392 — that appears to orchestrate much of the cellular chaos seen in severe COVID-19. By suppressing the body's energy centers, amplifying inflammation, and starving tissues of oxygen, this single regulatory molecule may explain why some infections spiral into crisis. The finding, still awaiting peer review, opens a quiet but consequential door: the possibility o
News-Medical.net
· Apr 27, 2021
· health
· 4 min de leitura
Medium
Apuração: Caracterizado
Researchers identify microRNA miR-2392 as potential COVID-19 driver and therapeutic target
◉
Health & Medicine
8098 artigos relacionados
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 100% correspondência
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 99% correspondência
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% correspondência
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% correspondência
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% correspondência
Cobertura Relacionada
The Guardian · Aug 20
Hundreds of thousands await GCSE results as gender gap narrows to 10-year low
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Researchers identify microRNA miR-2392 as COVID-19 severity driver with therapeutic potential, but this is a basic scientific discovery with minimal immediate geopolitical impact.
Escalation Risk
low
Confidence
HIGH
No significant shifts. Scientific collaboration between USA and UK continues in pandemic research; no competitive advantage or strategic implications identified.
Lente Econômica
📈
Researchers identified microRNA miR-2392 as a COVID-19 severity driver with therapeutic potential, offering new treatment avenue beyond vaccines for severe cases.
Market Signal
bullish
Confidence
MED
Biotechnology and Pharmaceuticals
Healthcare and Medical Services
Diagnostics and Biomarker Development
RNA Therapeutics
Potential future access to targeted COVID-19 treatments for severe cases, reducing hospitalization and mortality risks. May lower long-term healthcare costs for severe COVID-19 patients, though availability and affordability depend on clinical trial success and regulatory approval.
Likely acceleration of FDA/EMA regulatory pathways for miRNA-based therapeutics. Potential increased R&D funding for RNA medicine platforms. May influence public health strategies to incorporate biomarker-driven treatment protocols. Could affect healthcare reimbursement policies for personalized COVID-19 therapies.